Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

10 Items

per page
  1. MLN9708
    A4007 MLN9708
     3 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      insoluble in H2O; ≥20.85 mg/mL
  2. Celastrol
    A2604 Celastrol
    Target: Proteasome
    Summary: Antioxidant, anti-inflammatory and immunosuppressive agent
      ≥22.55 mg/mL
  3. Lactacystin (Synthetic)
    A2583 Lactacystin (Synthetic)
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      Soluble in H2O
  4. Epoxomicin
    A2606 Epoxomicin
     25 Citation
    Summary: Proteasome inhibitor
      ≥27.73 mg/mL
  5. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  6. Salinosporamide A (NPI-0052, Marizomib)
    A4010 Salinosporamide A (NPI-0052, Marizomib)
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      Soluble in DMSO
  7. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    Target: Proteasome
    Summary: Proteasome Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
  8. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, epoxomicin analog
      ≥35.99 mg/mL
  9. Gliotoxin
    A4443 Gliotoxin
     1 Citation
    Target: 20S proteasomal chymotrypsin|Geranylgeranyltransferase I|Farnesyltransferase
    Summary: 20S proteasome inhibitor
      Soluble in DMSO
  10. VR23
    B6026 VR23
    Target: Proteasome
    Summary: proteasome inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL

10 Items

per page